Tykhe Corp Stock Fundamentals

HALB Stock  USD 0  0.0003  8.33%   
Tykhe Corp fundamentals help investors to digest information that contributes to Tykhe Corp's financial success or failures. It also enables traders to predict the movement of Tykhe Pink Sheet. The fundamental analysis module provides a way to measure Tykhe Corp's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Tykhe Corp pink sheet.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Tykhe Corp Company Current Valuation Analysis

Tykhe Corp's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Tykhe Corp Current Valuation

    
  1.56 M  
Most of Tykhe Corp's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Tykhe Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Tykhe Corp has a Current Valuation of 1.56 M. This is 99.99% lower than that of the Healthcare sector and 99.97% lower than that of the Biotechnology industry. The current valuation for all United States stocks is 99.99% higher than that of the company.

Tykhe Corp Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Tykhe Corp's current stock value. Our valuation model uses many indicators to compare Tykhe Corp value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Tykhe Corp competition to find correlations between indicators driving Tykhe Corp's intrinsic value. More Info.
Tykhe Corp is one of the top stocks in return on asset category among its peers. It also is one of the top stocks in operating margin category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Tykhe Corp by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Tykhe Corp's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Tykhe Current Valuation Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Tykhe Corp's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Tykhe Corp could also be used in its relative valuation, which is a method of valuing Tykhe Corp by comparing valuation metrics of similar companies.
Tykhe Corp is currently under evaluation in current valuation category among its peers.

Tykhe Fundamentals

About Tykhe Corp Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Tykhe Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tykhe Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tykhe Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania. HALBERD CORP is traded on OTC Exchange in the United States.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Tykhe Pink Sheet

Tykhe Corp financial ratios help investors to determine whether Tykhe Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Tykhe with respect to the benefits of owning Tykhe Corp security.